OpenURL Connection Search

Select item for more details and to access through your institution.

Minimal number of circulating CD34+ cells to ensure successful leukapheresls and engraftment in autologons peripheral blood progenitor cell transplantation
Published in:
Transfusion, 1998, v. 38, n. 4, p. 385
By:
- Perez-Simon, J.A.;
- Caballero, M.D.;
- Corral, M.;
- Nieto, M.J.;
- Orfao, A.;
- Vazquez, L.;
- Amigo, M.L.;
- Berges, C.;
- Gonzdlez, M.;
- Del Canizo, C.;
- San Miguel, J.F.
Publication type:
Article
Immunoblastic lymphoma and associated non-lymphoid malignancies following two cases of Waldenström's macroglobulinemia. A review of the literature.
Published in:
European Journal of Haematology, 1993, v. 50, n. 5, p. 299, doi. 10.1111/j.1600-0609.1993.tb00167.x
By:
- García, R.;
- Hernández, J.M.;
- Caballero, M.D.;
- González, M.;
- Miguel, J.F. San
Publication type:
Article
A search for radio counterparts to Chandra ULX candidates.
Published in:
Astronomische Nachrichten, 2011, v. 332, n. 4, p. 384, doi. 10.1002/asna.201011505
By:
- Pérez-Ramírez, D.;
- Mezcua, M.;
- Leon, S.;
- Caballero-García, M.D.
Publication type:
Article
Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE-170 phase 2 trial.
Published in:
Hematological Oncology, 2017, v. 35, p. 62, doi. 10.1002/hon.2437_49
By:
- Zinzani, P.;
- Thieblemont, C.;
- Melnichenko, V.;
- Osmanov, D.;
- Bouabdallah, K.;
- Walewski, J.;
- Majlis, A.;
- Fogliatto, L.;
- Caballero Barrigón, M.D.;
- Christian, B.;
- Gulbas, Z.;
- Özcan, M.;
- Salles, G.A.;
- Shipp, M.A.;
- Balakumaran, A.;
- Chlosta, S.;
- Chatterjee, A.;
- Armand, P.
Publication type:
Article
DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST-AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12-YEAR FOLLOW-UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 32, doi. 10.1002/hon.2437_13
By:
- Pettengell, R.;
- Uddin, R.;
- Boumendil, A.;
- Robinson, S.P.;
- Smith, G.;
- Hawkins, T.;
- Metzner, B.;
- Caballero, M.D.;
- Tilly, H.;
- Romejko ‐ Jarosinska, J.;
- Bence ‐ Bruckler, I.;
- To, B.;
- Niemann, C.;
- Kimby, E.;
- Dreger, P.;
- Schmitz, N.;
- Goldstone, A.H.;
- Montoto, S.
Publication type:
Article

Found: 5

Minimal number of circulating CD34+ cells to ensure successful leukapheresls and engraftment in autologons peripheral blood progenitor cell transplantation

Immunoblastic lymphoma and associated non-lymphoid malignancies following two cases of Waldenström's macroglobulinemia. A review of the literature.

A search for radio counterparts to Chandra ULX candidates.

Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE-170 phase 2 trial.

DURABLE BENEFIT OF RITUXIMAB MAINTENANCE POST-AUTOGRAFT IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: 12-YEAR FOLLOW-UP OF THE EBMT LYMPHOMA WORKING PARTY LYM1 TRIAL.